Literature DB >> 8627303

Synaptic membrane G proteins are complexed with tubulin in situ.

K Yan1, E Greene, F Belga, M M Rasenick.   

Abstract

The G proteins G S and Gi1 appear to be capable of binding to tubulin specifically, and it has been suggested that such binding results in G protein activation via direct transfer of GTP. This study was undertaken to demonstrate that consequences of G protein activation by tubulin, i.e., stimulation or inhibition of adenyl cyclase, were dependent on the G proteins expressed as well as unique aspects of the membrane or cytoskeleton in a given cell type. Membranes from rat C6 glioma cells, which express G s alpha but not G i alpha 1, responded to the addition of tubulin with a stable activation of adenyl cyclase. Conversely, membranes from rat cerebral cortex, which contain both G s and G i 1, responded to exogenous tubulin with a stable inhibition of adenyl cyclase. Unlike C6 membranes, cerebral cortex membranes are richly endowed with tubulin, and antitubulin antibodies immunoprecipitated complexes of tubulin and G i 1 and G s from detergent extracts of these membranes. Nearly 90% of the G s alpha from Triton X-114 extracts coimmunoprecipitated with tubulin, suggesting that these proteins exist as a complex in the synaptic membrane. Such complexes may provide the framework for a G protein-cytoskeleton link that participates in the modulation of cellular signal transduction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627303     DOI: 10.1046/j.1471-4159.1996.66041489.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  A molecular and structural mechanism for G protein-mediated microtubule destabilization.

Authors:  Rahul H Davé; Witchuda Saengsawang; Manu Lopus; Sonya Davé; Leslie Wilson; Mark M Rasenick
Journal:  J Biol Chem       Date:  2010-11-26       Impact factor: 5.157

Review 2.  Heterotrimeric G-proteins interact directly with cytoskeletal components to modify microtubule-dependent cellular processes.

Authors:  Rahul H Dave; Witchuda Saengsawang; Jiang-Zhou Yu; Robert Donati; Mark M Rasenick
Journal:  Neurosignals       Date:  2009-02-12

Review 3.  Is signal transduction modulated by an interaction between heterotrimeric G-proteins and tubulin?

Authors:  R Ravindra
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

4.  Phosphatidylinositol 4,5-bisphosphate modifies tubulin participation in phospholipase Cbeta1 signaling.

Authors:  Juliana S Popova; Arin K Greene; Jia Wang; Mark M Rasenick
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 5.  Tubulin, actin and heterotrimeric G proteins: coordination of signaling and structure.

Authors:  Jeffrey M Schappi; Aleksandar Krbanjevic; Mark M Rasenick
Journal:  Biochim Biophys Acta       Date:  2013-09-23

6.  Lysophosphatidic acid and microtubule-destabilizing agents stimulate fibronectin matrix assembly through Rho-dependent actin stress fiber formation and cell contraction.

Authors:  Q Zhang; M K Magnusson; D F Mosher
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

7.  Muscarinic receptor activation promotes the membrane association of tubulin for the regulation of Gq-mediated phospholipase Cbeta(1) signaling.

Authors:  J S Popova; M M Rasenick
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

8.  Endogenous expression of adenosine A1, A2 and A3 receptors in rat C6 glioma cells.

Authors:  Carlos Alberto Castillo; José Luís Albasanz; Mercedes Fernández; Mairena Martín
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

Review 9.  Accessory proteins for heterotrimeric G-proteins in the kidney.

Authors:  Frank Park
Journal:  Front Physiol       Date:  2015-08-07       Impact factor: 4.566

10.  The lipid raft-dwelling protein US9 can be manipulated to target APP compartmentalization, APP processing, and neurodegenerative disease pathogenesis.

Authors:  Renato Brandimarti; Gordon S Hill; Jonathan D Geiger; Olimpia Meucci
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.